101 related articles for article (PubMed ID: 11434613)
1. Mechanism of novel vitamin K analog induced growth inhibition in human hepatoma cell line.
Osada S; Carr BI
J Hepatol; 2001 May; 34(5):676-82. PubMed ID: 11434613
[TBL] [Abstract][Full Text] [Related]
2. Involvement of hepatocyte epidermal growth factor receptor mediated activation of mitogen-activated protein kinase signaling pathways in response to growth inhibition by a novel K vitamin.
Wang Z; Wang M; Carr BI
J Cell Physiol; 2000 Jun; 183(3):338-46. PubMed ID: 10797308
[TBL] [Abstract][Full Text] [Related]
3. Critical role of extracellular signal-regulated kinase (ERK) phosphorylation in novel vitamin K analog-induced cell death.
Osada S; Carr BI
Jpn J Cancer Res; 2000 Dec; 91(12):1250-7. PubMed ID: 11123423
[TBL] [Abstract][Full Text] [Related]
4. K vitamins, PTP antagonism, and cell growth arrest.
Carr BI; Wang Z; Kar S
J Cell Physiol; 2002 Dec; 193(3):263-74. PubMed ID: 12384979
[TBL] [Abstract][Full Text] [Related]
5. Tumor cell growth inhibition and extracellular signal-regulated kinase (ERK) phosphorylation by novel K vitamins.
Osada S; Osada K; Carr BI
J Mol Biol; 2001 Dec; 314(4):765-72. PubMed ID: 11733995
[TBL] [Abstract][Full Text] [Related]
6. Critical role of extracellular signal-regulated kinase phosphorylation on menadione (vitamin K3) induced growth inhibition.
Osada S; Saji S; Osada K
Cancer; 2001 Mar; 91(6):1156-65. PubMed ID: 11267961
[TBL] [Abstract][Full Text] [Related]
7. Transient and sustained ERK phosphorylation and nuclear translocation in growth control.
Adachi T; Kar S; Wang M; Carr BI
J Cell Physiol; 2002 Aug; 192(2):151-9. PubMed ID: 12115721
[TBL] [Abstract][Full Text] [Related]
8. Phosphorylation regulates Myc expression via prolonged activation of the mitogen-activated protein kinase pathway.
Wang Z; Ge L; Wang M; Carr BI
J Cell Physiol; 2006 Jul; 208(1):133-40. PubMed ID: 16596619
[TBL] [Abstract][Full Text] [Related]
9. Grb2-associated binder-1 plays a central role in the hepatocyte growth factor enhancement of hepatoma growth inhibition by K vitamin analog compound 5.
Wang Z; Ge L; Wang M; Carr BI
Hepatology; 2007 Dec; 46(6):2003-13. PubMed ID: 18046719
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of hepatoma cell growth in vitro by arylating and non-arylating K vitamin analogs. Significance of protein tyrosine phosphatase inhibition.
Nishikawa Y; Wang Z; Kerns J; Wilcox CS; Carr BI
J Biol Chem; 1999 Dec; 274(49):34803-10. PubMed ID: 10574951
[TBL] [Abstract][Full Text] [Related]
11. Cell growth inhibition by a novel vitamin K is associated with induction of protein tyrosine phosphorylation.
Ni R; Nishikawa Y; Carr BI
J Biol Chem; 1998 Apr; 273(16):9906-11. PubMed ID: 9545333
[TBL] [Abstract][Full Text] [Related]
12. Involvement of Cdc25A phosphatase in Hep3B hepatoma cell growth inhibition induced by novel K vitamin analogs.
Wang Z; Southwick EC; Wang M; Kar S; Rosi KS; Wilcox CS; Lazo JS; Carr BI
Cancer Res; 2001 Oct; 61(19):7211-6. PubMed ID: 11585757
[TBL] [Abstract][Full Text] [Related]
13. Fluorinated Cpd 5, a pure arylating K-vitamin derivative, inhibits human hepatoma cell growth by inhibiting Cdc25 and activating MAPK.
Kar S; Wang M; Ham SW; Carr BI
Biochem Pharmacol; 2006 Nov; 72(10):1217-27. PubMed ID: 16930563
[TBL] [Abstract][Full Text] [Related]
14. EGFR-independent activation of ERK1/2 mediates growth inhibition by a PTPase antagonizing K-vitamin analog.
Kar S; Adachi T; Carr BI
J Cell Physiol; 2002 Mar; 190(3):356-64. PubMed ID: 11857451
[TBL] [Abstract][Full Text] [Related]
15. Hepatocyte growth factor enhances protein phosphatase Cdc25A inhibitor compound 5-induced hepatoma cell growth inhibition via Akt-mediated MAPK pathway.
Wang Z; Wang M; Carr BI
J Cell Physiol; 2005 Jun; 203(3):510-9. PubMed ID: 15534860
[TBL] [Abstract][Full Text] [Related]
16. Antitumor and anticarcinogenic actions of Cpd 5: a new class of protein phosphatase inhibitor.
Kar S; Wang M; Wilcox CS; Carr BI
Carcinogenesis; 2003 Mar; 24(3):411-6. PubMed ID: 12663499
[TBL] [Abstract][Full Text] [Related]
17. H32, a non-quinone sulfone analog of vitamin K3, inhibits human hepatoma cell growth by inhibiting Cdc25 and activating ERK.
Kar S; Wang M; Ham SW; Carr BI
Cancer Biol Ther; 2006 Oct; 5(10):1340-7. PubMed ID: 16969075
[TBL] [Abstract][Full Text] [Related]
18. Cdc25A and ERK interaction: EGFR-independent ERK activation by a protein phosphatase Cdc25A inhibitor, compound 5.
Wang Z; Zhang B; Wang M; Carr BI
J Cell Physiol; 2005 Aug; 204(2):437-44. PubMed ID: 15672448
[TBL] [Abstract][Full Text] [Related]
19. Grape seed extract inhibits EGF-induced and constitutively active mitogenic signaling but activates JNK in human prostate carcinoma DU145 cells: possible role in antiproliferation and apoptosis.
Tyagi A; Agarwal R; Agarwal C
Oncogene; 2003 Mar; 22(9):1302-16. PubMed ID: 12618755
[TBL] [Abstract][Full Text] [Related]
20. PM-20, a novel inhibitor of Cdc25A, induces extracellular signal-regulated kinase 1/2 phosphorylation and inhibits hepatocellular carcinoma growth in vitro and in vivo.
Kar S; Wang M; Yao W; Michejda CJ; Carr BI
Mol Cancer Ther; 2006 Jun; 5(6):1511-9. PubMed ID: 16818510
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
